ETXPF
Price
$0.13
Change
-$0.01 (-7.14%)
Updated
Apr 16 closing price
ZIVO
Price
$15.87
Change
-$4.13 (-20.65%)
Updated
Dec 17 closing price
Ad is loading...

ETXPF vs ZIVO

Header iconETXPF vs ZIVO Comparison
Open Charts ETXPF vs ZIVOBanner chart's image
E-Therapeutics
Price$0.13
Change-$0.01 (-7.14%)
Volume$10K
CapitalizationN/A
Zivo Bioscience
Price$15.87
Change-$4.13 (-20.65%)
Volume$2.53K
CapitalizationN/A
ETXPF vs ZIVO Comparison Chart
Loading...
View a ticker or compare two or three
VS
ETXPF vs. ZIVO commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ETXPF is a Hold and ZIVO is a Hold.

COMPARISON
Comparison
Dec 19, 2024
Stock price -- (ETXPF: $0.13 vs. ZIVO: $15.87)
Brand notoriety: ETXPF and ZIVO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ETXPF: 100% vs. ZIVO: 152%
Market capitalization -- ETXPF: $75.96M vs. ZIVO: $68.27M
ETXPF [@Biotechnology] is valued at $75.96M. ZIVO’s [@Biotechnology] market capitalization is $68.27M. The market cap for tickers in the [@Biotechnology] industry ranges from $482.14B to $0. The average market capitalization across the [@Biotechnology] industry is $2.68B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ETXPF’s FA Score shows that 0 FA rating(s) are green whileZIVO’s FA Score has 0 green FA rating(s).

  • ETXPF’s FA Score: 0 green, 5 red.
  • ZIVO’s FA Score: 0 green, 5 red.
According to our system of comparison, ZIVO is a better buy in the long-term than ETXPF.

Price Growth

ETXPF (@Biotechnology) experienced а 0.00% price change this week, while ZIVO (@Biotechnology) price change was -18.41% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -6.67%. For the same industry, the average monthly price growth was -1.91%, and the average quarterly price growth was -1.42%.

Reported Earning Dates

ZIVO is expected to report earnings on Feb 28, 2024.

Industries' Descriptions

@Biotechnology (-6.67% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

FUNDAMENTALS
Fundamentals
ETXPF($76M) has a higher market cap than ZIVO($56.3M). ZIVO YTD gains are higher at: 1222.500 vs. ETXPF (0.000).
ETXPFZIVOETXPF / ZIVO
Capitalization76M56.3M135%
EBITDAN/AN/A-
Gain YTD0.0001222.500-
P/E RatioN/AN/A-
RevenueN/AN/A-
Total CashN/A139K-
Total DebtN/A779K-
FUNDAMENTALS RATINGS
ZIVO: Fundamental Ratings
ZIVO
OUTLOOK RATING
1..100
60
VALUATION
overvalued / fair valued / undervalued
1..100
85
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
34
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
20

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
RSI
ODDS (%)
Stochastic
ODDS (%)
Momentum
ODDS (%)
MACD
ODDS (%)
TrendWeek
ODDS (%)
TrendMonth
ODDS (%)
Advances
ODDS (%)
Declines
ODDS (%)
BollingerBands
ODDS (%)
Aroon
ODDS (%)
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME31.261.82
+6.18%
GameStop Corp
TSLA479.8616.84
+3.64%
Tesla
AAPL253.482.44
+0.97%
Apple
BTC.X106140.600000110.890625
+0.10%
Bitcoin cryptocurrency
SPY604.29-2.50
-0.41%
SPDR® S&P 500® ETF Trust

ETXPF and

Correlation & Price change

A.I.dvisor indicates that over the last year, ETXPF has been loosely correlated with MTVA. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if ETXPF jumps, then MTVA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ETXPF
1D Price
Change %
ETXPF100%
N/A
MTVA - ETXPF
52%
Loosely correlated
+1.75%
TYRA - ETXPF
42%
Loosely correlated
+1.06%
KPRX - ETXPF
37%
Loosely correlated
-3.06%
COGT - ETXPF
33%
Poorly correlated
-0.85%
BRTX - ETXPF
24%
Poorly correlated
+6.16%
More

ZIVO and

Correlation & Price change

A.I.dvisor tells us that ZIVO and MDXXF have been poorly correlated (+22% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ZIVO and MDXXF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ZIVO
1D Price
Change %
ZIVO100%
-20.65%
MDXXF - ZIVO
22%
Poorly correlated
-4.07%
ATXS - ZIVO
21%
Poorly correlated
-1.24%
ETXPF - ZIVO
21%
Poorly correlated
N/A
COGT - ZIVO
20%
Poorly correlated
-0.85%
CLSD - ZIVO
20%
Poorly correlated
+0.99%
More